Tomas Navratil
Corporate Officer/Principal presso GLAUKOS CORPORATION
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Tomas Navratil is currently the Chief Development Officer at Glaukos Corp.
He also holds a position on the Member-Supervisory Board at Severomoravske Vodovody a Kanalizace Ostrava as.
Previously, he worked as the Director-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc., the Executive Director-Clinical Research at Parion Sciences, Inc., the General Manager at Nicox Ophthalmics, Inc., the Executive VP, Global Head-Research & Development at Nicox SA, and the Senior Vice President-Development at Envisia Therapeutics, Inc. Dr. Navratil obtained his undergraduate and doctorate degrees from The University of North Carolina at Charlotte.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GLAUKOS CORP
0.05% | 05/04/2024 | 25 075 ( 0.05% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Tomas Navratil
Società | Posizione | Inizio |
---|---|---|
GLAUKOS CORPORATION | Corporate Officer/Principal | 01/04/2022 |
Severomoravske Vodovody a Kanalizace Ostrava as
Severomoravske Vodovody a Kanalizace Ostrava as Water UtilitiesUtilities Severomoravske Vodovody a Kanalizace Ostrava AS engages in the production and supply of drinking water. It also deals with the discharge and treatment of wastewater. The company was founded on April 30, 1992 and is headquartered in Ostrava, Czech Republic. | Director/Board Member | - |
Precedenti posizioni note di Tomas Navratil
Società | Posizione | Fine |
---|---|---|
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | - |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Chief Tech/Sci/R&D Officer | - |
NICOX SA | Chief Tech/Sci/R&D Officer | - |
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Corporate Officer/Principal | - |
Formazione di Tomas Navratil
The University of North Carolina at Charlotte | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GLAUKOS CORPORATION | Health Technology |
NICOX SA | Health Technology |
Aziende private | 5 |
---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Commercial Services |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
Severomoravske Vodovody a Kanalizace Ostrava as
Severomoravske Vodovody a Kanalizace Ostrava as Water UtilitiesUtilities Severomoravske Vodovody a Kanalizace Ostrava AS engages in the production and supply of drinking water. It also deals with the discharge and treatment of wastewater. The company was founded on April 30, 1992 and is headquartered in Ostrava, Czech Republic. | Utilities |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Health Technology |
- Borsa valori
- Insiders
- Tomas Navratil